Meeting of the Community Preventive Services Task Force (Task Force), 56586-56587 [2014-22502]

Download as PDF 56586 Federal Register / Vol. 79, No. 183 / Monday, September 22, 2014 / Notices designs that address: The target population to which generalizations will be made, the sampling frame, the sample design (including stratification and clustering), the precision requirements or power calculations that justify the proposed sample size, the expected response rate, methods for assessing potential non-response bias, the protocols for data collection, and any testing procedures that were or will be undertaken prior fielding the study. Depending on the degree of influence the results are likely to have, such collections may still be eligible for submission for other generic mechanisms that are designed to yield quantitative results. Below we provide AHRQ’s projected average annual estimates for the next three years: Current Actions: New collection of information. Type of Review: New Collection. Affected Public: Individuals and Households, Businesses and Organizations, State, Local or Tribal Government. Average Expected Annual Number of activities: 10. Respondents: 10,900. Annual responses: 10,900. Frequency of Response: Once per request. The total number of respondents across all 10 activities in a given year is 10,900. Average minutes per response: 19. Burden hours: 3,452. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid Office of Management and Budget control number. asabaliauskas on DSK5VPTVN1PROD with NOTICES Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ health care research and health care information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. VerDate Sep<11>2014 17:07 Sep 19, 2014 Jkt 232001 Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of Public record. Dated: September 11, 2014. Richard Kronick, Director. [FR Doc. 2014–22214 Filed 9–19–14; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Meeting of the Community Preventive Services Task Force (Task Force) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The Centers for Disease Control and Prevention (CDC) announces the next meeting of the Community Preventive Services Task Force (Task Force). The Task Force is an independent, nonpartisan, nonfederal, and unpaid panel. Its members represent a broad range of research, practice, and policy expertise in prevention, wellness, health promotion, and public health, and are appointed by the CDC Director. The Task Force was convened in 1996 by the Department of Health and Human Services (HHS) to identify community preventive programs, services, and policies that increase healthy longevity, save lives and dollars and improve Americans’ quality of life. CDC is mandated to provide ongoing administrative, research, and technical support for the operations of the Task Force. During its meetings, the Task Force considers the findings of systematic reviews on existing research, and issues recommendations. Task Force recommendations provide information about evidence-based options that decision makers and stakeholders can consider when determining what best meets the specific needs, preferences, available resources, and constraints of their jurisdictions and constituents. The Task Force’s recommendations, along with the systematic reviews of the scientific evidence on which they are based, are compiled in the Guide to Community Preventive Services (Community Guide). DATES: The meeting will be held on Wednesday, October 29, 2014 from 8:30 SUMMARY: PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 a.m. to 6:00 p.m. EDT and Thursday, October 30, 2014 from 8:30 a.m. to 1:00 p.m. EDT. ADDRESSES: The Task Force Meeting will be held at CDC Edward R. Roybal Campus, Tom Harkin Global Communications Center (Building 19), 1600 Clifton Road NE., Atlanta, GA 30333. You should be aware that the meeting location is in a Federal government building; therefore, Federal security measures are applicable. For additional information, please see Roybal Campus Security Guidelines under SUPPLEMENTARY INFORMATION. Information regarding meeting logistics will be available on the Community Guide Web site (www.thecommunityguide.org). Meeting Accessibility: This meeting is open to the public, limited only by space availability in the meeting location. All meeting attendees must RSVP to ensure the required security procedures are completed to gain access to the CDC’s Global Communications Center. U.S. citizens must RSVP by 10/03/ 2014. Non U.S. citizens must RSVP by 9/26/ 2014 due to additional security steps that must be completed. In addition to in-person participation, individuals may view presentations via live video stream on the Internet. Those interested in accessing the live stream must also RSVP, and additional information will be sent to registrants requesting connectivity via the Internet in advance of the meeting. Failure to RSVP by the dates identified could result in an inability to attend the Task Force meeting due to the strict security regulations on federal facilities. FOR FURTHER INFORMATION AND TO RSVP CONTACT: Terica Scott, The Community Guide Branch; Division of Epidemiology, Analysis, and Library Services; Center for Surveillance, Epidemiology and Laboratory Services; Office of Public Health Scientific Services; Centers for Disease Control and Prevention, 1600 Clifton Road, MS– E–69, Atlanta, GA 30333, phone: (404) 498–6360, email: CPSTF@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The purpose of the meeting is for the Task Force to consider the findings of systematic reviews and issue findings and recommendations. Task Force recommendations provide information about evidence-based options that decision makers and stakeholders can consider when determining what best meets the specific needs, preferences, available resources, and constraints of their jurisdictions and constituents. E:\FR\FM\22SEN1.SGM 22SEN1 Federal Register / Vol. 79, No. 183 / Monday, September 22, 2014 / Notices Matters to be discussed: Diabetes, cardiovascular disease, and promoting health equity. Topics are subject to change. Roybal Campus Security Guidelines: The Edward R. Roybal Campus is the headquarters of the U.S. Centers for Disease Control and Prevention and is located at 1600 Clifton Road NE., Atlanta, Georgia. The meeting is being held in a Federal government building; therefore, Federal security measures are applicable. All meeting attendees must RSVP by the dates outlined under Meeting Accessability. In planning your arrival time, please take into account the need to park and clear security. All visitors must enter the Roybal Campus through the entrance on Clifton Road. Your car may be searched, and the guard force will then direct visitors to the designated parking area. Upon arrival at the facility, visitors must present government issued photo identification (e.g., a valid federal identification badge, state driver’s license, state nondriver’s identification card, or passport). Non-United States citizens must complete the required security paperwork prior to the meeting date and must present a valid passport, visa, Permanent Resident Card, or other type of work authorization document upon arrival at the facility. All persons entering the building must pass through a metal detector. Visitors will be issued a visitor’s ID badge at the entrance to Building 19 and may be escorted to the meeting room. All items brought to HHS/CDC are subject to inspection. DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–0487] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Food and Drug Administration Service Delivery AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (PRA). SUMMARY: Fax written comments on the collection of information by October 22, 2014. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–7285, or emailed to oira_ submission@omb.eop.gov. All comments should be identified with the OMB control number 0910–0697. Also include the FDA docket number found in brackets in the heading of this document. DATES: [FR Doc. 2014–22502 Filed 9–19–14; 8:45 am] FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. BILLING CODE 4163–18–P SUPPLEMENTARY INFORMATION: Dated: September 17, 2014. Ron A. Otten, Acting Deputy Associate Director for Science, Centers for Disease Control and Prevention. FOR FURTHER INFORMATION CONTACT: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. asabaliauskas on DSK5VPTVN1PROD with NOTICES Generic Clearance for the Collection of Qualitative Feedback on FDA Service Delivery—(OMB Control Number 0910– 0697)—Extension The information collection activity will garner qualitative customer and stakeholder feedback in an efficient, VerDate Sep<11>2014 17:07 Sep 19, 2014 Jkt 232001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 56587 timely manner, in accordance with the Administration’s commitment to improving service delivery. By qualitative feedback, FDA means information that provides useful insight on perceptions and opinions, not statistical surveys that yield quantitative results that can be generalized to the population of study. This feedback will provide insight into customer or stakeholder perceptions; experiences and expectations; provide an early warning of issues with service; or focus attention on areas where communication, training, or changes in operations might improve delivery of products or services. This information collection will allow for ongoing collaborative and actionable communications among the FDA and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management. Feedback collected under this generic clearance will provide useful information, but it will not yield data that can be generalized to the overall population. This type of generic clearance for qualitative information will not be used for quantitative information collections that are designed to yield reliably actionable results, such as monitoring trends over time or documenting program performance. Such data uses require more rigorous designs that address the following: The target population to which the generalizations will be made, the sampling frame, the sample design (including stratification and clustering), the precision requirements or power calculations that justify the proposed sample size, the expected response rate, the methods for assessing potential nonresponse bias, the protocols for data collection, and any testing procedures that were or will be undertaken prior to fielding the study. Depending on the degree of influence the results are likely to have, such collections may still be eligible for submission for other generic mechanisms that are designed to yield quantitative results. In the Federal Register of April 29, 2014 (79 FR 23980), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received. FDA estimates the burden of this collection of information as follows: E:\FR\FM\22SEN1.SGM 22SEN1

Agencies

[Federal Register Volume 79, Number 183 (Monday, September 22, 2014)]
[Notices]
[Pages 56586-56587]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22502]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Community Preventive Services Task Force (Task 
Force)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) announces 
the next meeting of the Community Preventive Services Task Force (Task 
Force). The Task Force is an independent, nonpartisan, nonfederal, and 
unpaid panel. Its members represent a broad range of research, 
practice, and policy expertise in prevention, wellness, health 
promotion, and public health, and are appointed by the CDC Director. 
The Task Force was convened in 1996 by the Department of Health and 
Human Services (HHS) to identify community preventive programs, 
services, and policies that increase healthy longevity, save lives and 
dollars and improve Americans' quality of life. CDC is mandated to 
provide ongoing administrative, research, and technical support for the 
operations of the Task Force. During its meetings, the Task Force 
considers the findings of systematic reviews on existing research, and 
issues recommendations. Task Force recommendations provide information 
about evidence-based options that decision makers and stakeholders can 
consider when determining what best meets the specific needs, 
preferences, available resources, and constraints of their 
jurisdictions and constituents. The Task Force's recommendations, along 
with the systematic reviews of the scientific evidence on which they 
are based, are compiled in the Guide to Community Preventive Services 
(Community Guide).

DATES: The meeting will be held on Wednesday, October 29, 2014 from 
8:30 a.m. to 6:00 p.m. EDT and Thursday, October 30, 2014 from 8:30 
a.m. to 1:00 p.m. EDT.

ADDRESSES: The Task Force Meeting will be held at CDC Edward R. Roybal 
Campus, Tom Harkin Global Communications Center (Building 19), 1600 
Clifton Road NE., Atlanta, GA 30333. You should be aware that the 
meeting location is in a Federal government building; therefore, 
Federal security measures are applicable. For additional information, 
please see Roybal Campus Security Guidelines under SUPPLEMENTARY 
INFORMATION. Information regarding meeting logistics will be available 
on the Community Guide Web site (www.thecommunityguide.org).
    Meeting Accessibility: This meeting is open to the public, limited 
only by space availability in the meeting location. All meeting 
attendees must RSVP to ensure the required security procedures are 
completed to gain access to the CDC's Global Communications Center.
    U.S. citizens must RSVP by 10/03/2014.
    Non U.S. citizens must RSVP by 9/26/2014 due to additional security 
steps that must be completed.
    In addition to in-person participation, individuals may view 
presentations via live video stream on the Internet. Those interested 
in accessing the live stream must also RSVP, and additional information 
will be sent to registrants requesting connectivity via the Internet in 
advance of the meeting. Failure to RSVP by the dates identified could 
result in an inability to attend the Task Force meeting due to the 
strict security regulations on federal facilities.

FOR FURTHER INFORMATION AND TO RSVP CONTACT:  Terica Scott, The 
Community Guide Branch; Division of Epidemiology, Analysis, and Library 
Services; Center for Surveillance, Epidemiology and Laboratory 
Services; Office of Public Health Scientific Services; Centers for 
Disease Control and Prevention, 1600 Clifton Road, MS-E-69, Atlanta, GA 
30333, phone: (404) 498-6360, email: CPSTF@cdc.gov.

SUPPLEMENTARY INFORMATION:
    Purpose: The purpose of the meeting is for the Task Force to 
consider the findings of systematic reviews and issue findings and 
recommendations. Task Force recommendations provide information about 
evidence-based options that decision makers and stakeholders can 
consider when determining what best meets the specific needs, 
preferences, available resources, and constraints of their 
jurisdictions and constituents.

[[Page 56587]]

    Matters to be discussed: Diabetes, cardiovascular disease, and 
promoting health equity. Topics are subject to change.
    Roybal Campus Security Guidelines: The Edward R. Roybal Campus is 
the headquarters of the U.S. Centers for Disease Control and Prevention 
and is located at 1600 Clifton Road NE., Atlanta, Georgia. The meeting 
is being held in a Federal government building; therefore, Federal 
security measures are applicable.
    All meeting attendees must RSVP by the dates outlined under Meeting 
Accessability. In planning your arrival time, please take into account 
the need to park and clear security. All visitors must enter the Roybal 
Campus through the entrance on Clifton Road. Your car may be searched, 
and the guard force will then direct visitors to the designated parking 
area. Upon arrival at the facility, visitors must present government 
issued photo identification (e.g., a valid federal identification 
badge, state driver's license, state non-driver's identification card, 
or passport). Non-United States citizens must complete the required 
security paperwork prior to the meeting date and must present a valid 
passport, visa, Permanent Resident Card, or other type of work 
authorization document upon arrival at the facility. All persons 
entering the building must pass through a metal detector. Visitors will 
be issued a visitor's ID badge at the entrance to Building 19 and may 
be escorted to the meeting room. All items brought to HHS/CDC are 
subject to inspection.

    Dated: September 17, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-22502 Filed 9-19-14; 8:45 am]
BILLING CODE 4163-18-P